Mr. Mitchell Geisler reports

LEVELJUMP ANNOUNCES $2.5 MILLION NON-BROKERED PRIVATE PLACEMENT

Leveljump Healthcare Corp. will be conducting a non-brokered private placement financing of up to 16,666,667 units at 15 cents per unit for gross proceeds of up to $2.5-million.

Each unit will consist of one common share of Leveljump and one common share purchase warrant. Each warrant will entitle the holder to acquire one additional common share of Leveljump at an exercise price of 20 cents with an expiry date of Jan. 31, 2024.

The offering is only open to residents of Canada who are accredited investors as defined under applicable securities legislation. It is the intention that the principal subscribers will include strategic investors made up of private investment funds and high-net-worth investors in support of the long-term vision of the company.

The net proceeds from the financing will be used toward acquisitions and for general working capital purposes.

The offering is expected to close in late January, 2022. The offering is conditional upon receipt of all required regulatory approvals, including the approval of the TSX Venture Exchange. The securities to be issued under the offering will have a hold period of four months and one day from the closing date of the offering in accordance with applicable securities laws.

About Leveljump Healthcare Corp.

Leveljump Healthcare is building a national medical diagnostic imaging company and brand, primarily by providing teleradiology (remote radiology) services to its client hospitals and imaging centres. Additionally, Leveljump plans to expand through the acquisition of independent health care facilities focused on diagnostic imaging as well as acquiring new disruptive imaging technologies.

We seek Safe Harbor.